CTOs on the Move

Cerevel

www.cerevel.com

 
Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson`s, Alzheimer`s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.cerevel.com
  • 222 Jacobs Street Suite 200
    Cambridge, MA USA 02141
  • Phone: 844.304.2048

Executives

Name Title Contact Details

Funding

Cerevel raised $125M on 04/13/2021
Cerevel raised $350M on 07/01/2021

Similar Companies

UniQure

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.

Quality Care Solutions Inc

Quality Care Solutions Inc is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Karuna Pharmaceuticals

Karuna Pharmaceuticals is a clinical-stage company targeting muscarinic cholinergic receptors for the treatment of psychosis and cognitive impairment across central nervous system (CNS) disorders.

Osco Drug

Osco Drug is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mccrone Group Inc

Mccrone Group Inc is a Westmont, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.